Convincing experimental data indicate that EGF plays an important role in cancer development but not as an “initiating” agent (14) although a recent multicenter investigation demonstrated that the incidence of cancer was comparable between subjects treated with EGF and control subjects treated only with sulfadiazine. This evidence concerns the gene EGF and cancer.